Demographic Profile of p16 Immunopositive and HPV DNA PCR Positive Oral Squamous Cell Carcinoma in a Large Cohort of Indian Patients.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 Feb 2022
Historique:
received: 22 09 2021
entrez: 28 2 2022
pubmed: 1 3 2022
medline: 12 3 2022
Statut: epublish

Résumé

The Indian subcontinent has the highest incidence of oral cavity squamous cell carcinoma in the world. The high incidence of tobacco chewing habit with or without smoking has been found to be the chief culprit. However in a minor subset of patients Human Papilloma Virus may play a role. A total of 800 cases of Oral squamous cell carcinoma were included in the study. The patients were given a questionnaire comprising of questions about demographic details and habits. The biopsy samples were routinely processed for immunohistochemistry for p16 (E6H4 clone, CINtec histology, Roche diagnostics). Cases with 2+/3+ positive nuclear staining with more than 75% cells immunopositive were taken as p16 immunopositive as per the AJCC criteria and were further subjected to HPV DNA PCR for which DNA was extracted from the formalin fixed paraffin embedded tissue. Out of 800 OSCC cases 139 (17.37%) showed p16 immunopositivity by AJCC criteria. Out of these, 104 (104/139, 74.8%) cases were positive by HPV DNA PCR for HPV-16/18. Following patient characteristics were associated with a higher proportion of p16 and HPV DNA positivity-urban residence, vegetarian diet, illiteracy, graduate or higher education. No correlation was noted with gender, tobacco smoking or chewing habits, religion, occupation or site of tumor. The p16 immunopositivity was higher in the younger age group with no tobacco habits. A significant proportion of OSCC cases in India are associated with HPV infection. A higher percentage of p16 immunopositivity amongst younger patients with no tobacco habits points towards a distinct subset of patients in whom HPV may be the chief culprit and not just playing a supporting role.

Sections du résumé

BACKGROUND BACKGROUND
The Indian subcontinent has the highest incidence of oral cavity squamous cell carcinoma in the world. The high incidence of tobacco chewing habit with or without smoking has been found to be the chief culprit. However in a minor subset of patients Human Papilloma Virus may play a role.
MATERIALS AND METHODS METHODS
A total of 800 cases of Oral squamous cell carcinoma were included in the study. The patients were given a questionnaire comprising of questions about demographic details and habits. The biopsy samples were routinely processed for immunohistochemistry for p16 (E6H4 clone, CINtec histology, Roche diagnostics). Cases with 2+/3+ positive nuclear staining with more than 75% cells immunopositive were taken as p16 immunopositive as per the AJCC criteria and were further subjected to HPV DNA PCR for which DNA was extracted from the formalin fixed paraffin embedded tissue.
RESULTS RESULTS
Out of 800 OSCC cases 139 (17.37%) showed p16 immunopositivity by AJCC criteria. Out of these, 104 (104/139, 74.8%) cases were positive by HPV DNA PCR for HPV-16/18. Following patient characteristics were associated with a higher proportion of p16 and HPV DNA positivity-urban residence, vegetarian diet, illiteracy, graduate or higher education. No correlation was noted with gender, tobacco smoking or chewing habits, religion, occupation or site of tumor. The p16 immunopositivity was higher in the younger age group with no tobacco habits.
CONCLUSION CONCLUSIONS
A significant proportion of OSCC cases in India are associated with HPV infection. A higher percentage of p16 immunopositivity amongst younger patients with no tobacco habits points towards a distinct subset of patients in whom HPV may be the chief culprit and not just playing a supporting role.

Identifiants

pubmed: 35225465
doi: 10.31557/APJCP.2022.23.2.529
pmc: PMC9272603
pii:
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-536

Références

Front Oncol. 2020 Nov 25;10:524928
pubmed: 33324540
PLoS One. 2021 Jun 17;16(6):e0253418
pubmed: 34138935
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):292-299
pubmed: 31219104
Tob Induc Dis. 2019 Apr 12;17:29
pubmed: 31582940
Int J Cancer. 2010 Apr 15;126(8):1882-1894
pubmed: 19795456
J Surg Oncol. 2012 Aug 1;106(2):149-54
pubmed: 22354873
Expert Rev Anticancer Ther. 2019 Feb;19(2):105-119
pubmed: 30582397
Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2407-2412
pubmed: 32342197
Front Public Health. 2019 Jan 31;7:4
pubmed: 30766863
Oral Dis. 2016 Sep;22(6):517-22
pubmed: 26993152
Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):724-32
pubmed: 25611240
Mod Pathol. 2000 Jun;13(6):644-53
pubmed: 10874669
Sci Rep. 2020 Aug 6;10(1):13219
pubmed: 32764593
Cancer Med. 2017 May;6(5):910-917
pubmed: 28378539
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
pubmed: 15734974
J Gen Virol. 2018 Jun;99(6):783-789
pubmed: 29708483
Epidemiol Mikrobiol Imunol. 2020 Spring;69(2):64-72
pubmed: 32819105
J Clin Microbiol. 2010 Mar;48(3):758-64
pubmed: 20042614
Nutrients. 2018 Apr 11;10(4):
pubmed: 29641467
J Glob Oncol. 2018 Nov;4:1-33
pubmed: 30398949
Oral Oncol. 2014 May;50(5):370-9
pubmed: 24331868
Indian J Surg Oncol. 2020 Jun;11(2):248-255
pubmed: 32523271
Neoplasma. 2012;59(4):398-408
pubmed: 22489695
World J Otorhinolaryngol Head Neck Surg. 2020 Mar 06;6(1):66-75
pubmed: 32426706
Int J Cancer. 2005 Mar 1;113(6):946-50
pubmed: 15514945
Mod Pathol. 2017 Sep;30(9):1194-1203
pubmed: 28621317
Pathol Res Pract. 2011 Dec 15;207(12):758-61
pubmed: 22055991

Auteurs

Farhat Naz (F)

Lab Oncology Unit, DR. BRA IRCH, All India Institute of Medical Sciences, AIIMS- Delhi, New Delhi, India.

Hitesh Verma (H)

Department of ENT, Teaching Block, All India Institute of Medical Sciences, AIIMS- Delhi, New Delhi, India.

Nadeem Tanveer (N)

Department of Pathology, University College of Medical Sciences: Delhi, Delhi, India.

Arava Kumar Sudheer (AK)

Department of Pathology, Teaching Block, All India Institute of Medical Sciences, AIIMS-Delhi, New Delhi, India.

Aanchal Kakkar (A)

Department of Pathology, Teaching Block, All India Institute of Medical Sciences, AIIMS-Delhi, New Delhi, India.

Pranay Tanwar (P)

Lab Oncology Unit, DR. BRA IRCH, All India Institute of Medical Sciences, AIIMS- Delhi, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH